Valuation: Repligen Corporation

Market Cap 11.03B 9.95B 9.19B 8.31B 15.71B 1,035B 16.1B 110B 43.89B 554B 41.41B 40.53B 1,764B P/E 2026 *
-578x
P/E 2027 * 119x
Enterprise Value 10.22B 9.21B 8.51B 7.7B 14.56B 959B 14.92B 102B 40.66B 514B 38.37B 37.55B 1,634B EV / Sales 2026 *
12x
EV / Sales 2027 * 9.36x
Free-Float
94.98%
Yield 2026 *
-
Yield 2027 * -
1 day-0.78%
1 week-3.13%
Current month-2.44%
1 month-0.72%
3 months+4.76%
6 months+48.93%
Current year+5.35%
1 week 168.05
Extreme 168.05
181.02
1 month 164.88
Extreme 164.88
191.05
Current year 100.99
Extreme 100.99
198.87
1 year 100.99
Extreme 100.99
198.87
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
300.23
10 years 28.48
Extreme 28.475
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Director/Board Member 61 2020-02-29
Date Insider Type Main position Quantity % Market Cap. Importance
10/6/26 Free

Executive/Senior Manager

1,375 0.0024%
10/5/26 Sell

Chief Executive Officer

-13,939 0.0247%
10/2/26 Tax

Chief Executive Officer

-1,248 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%-3.13%+12.50%+16.98% 11.12B
-1.06%-5.38%-13.94%+16.30% 191B
+0.02%-3.19%+6.51%+43.76% 124B
-1.70%-6.14%-12.35%+16.51% 123B
-2.69%-3.46%-42.12%+4.37% 96.14B
+0.34%-1.16%-4.16%+77.09% 66.54B
+0.90%+2.55%+13.49%-8.58% 57.91B
+0.85%+0.58%-1.39%+63.88% 54.89B
+2.05%+1.16%-0.65%+58.05% 49.1B
-3.88%-6.01%-3.60%-8.41% 36.19B
Average -0.59%-1.74%-4.57%+28.00% 81B
Weighted average by Cap. -0.73%-2.88%-8.66%+26.99%

Financials

2026 *2027 *
Net sales 849M 765M 707M 639M 1.21B 79.61B 1.24B 8.47B 3.38B 42.64B 3.19B 3.12B 136B 1.07B 964M 891M 805M 1.52B 100B 1.56B 10.67B 4.25B 53.73B 4.01B 3.93B 171B
Net income -19.07M -17.19M -15.88M -14.36M -27.16M -1.79B -27.83M -190M -75.86M -958M -71.58M -70.06M -3.05B 89.14M 80.34M 74.23M 67.1M 127M 8.36B 130M 890M 355M 4.48B 335M 327M 14.25B
Net Debt -811M -731M -675M -610M -1.15B -76.06B -1.18B -8.09B -3.23B -40.73B -3.04B -2.98B -130B -1.02B -921M -851M -769M -1.46B -95.83B -1.49B -10.2B -4.06B -51.32B -3.83B -3.75B -163B
Projected Income Statement - Annual - Repligen Corporation
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-11-11 $172.62 -0.78% 1,000,618
26-11-10 $173.98 -2.77% 678,645
26-11-09 $178.94 +3.14% 1,096,250
26-11-06 $173.49 +2.97% 1,069,909
26-11-05 $168.48 -5.45% 1,332,428
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Repligen Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
172.62USD
Average target price
203.21USD
Spread / Average Target
+17.72%
  1. Stock Market
  2. Stocks
  3. RGEN Stock